Skip to content
Tuesday, November 17, 2026
TechSphere

Giving Stem Cells During Pregnancy to Infants with Spina Bifida Enhances Quality of Life, Research Shows

A groundbreaking research effort has found that providing pluripotent cells to unborn babies affected by spina bifida during corrective surgery may represent a "major milestone" in treating birth defects.

Study Parameters and Security

The American study examined six fetuses with a severe neural tube defect. Surgeons applied regenerative cells sourced from the maternal placenta directly onto the developing neural column during the repair procedure.

Importantly, the cell therapy was found to be safe. Researchers confirmed that the treatment did not lead to cancerous growths, interfere with wound healing, or impede the resolution of associated brain abnormalities.

Encouraging Results

Post-birth MRI scans showed a full resolution of hindbrain herniation in each of the babies. This neurological improvement is strongly associated with enhanced physical outcomes.

"If it makes a greater number of infants to achieve ambulation who wouldn't have, then it would become the conventional approach," said the lead researcher. "The results are extremely promising and create a pathway toward numerous possible innovative interventions."

Future Implications and Hope

Commentators reviewing the findings indicated that subsequent studies of these observed advantages could herald a "fresh chapter" in fetal surgery. The prospect of enhancing neural deficits present before birth is regarded as a transformative goal.

Particularly welcome would be improvements in urogenital and gastrointestinal outcomes, which are frequent complications for individuals living with this defect.

Future Directions

While this initial trial focused on a handful of cases, its confirmed tolerability and hopeful trends provide a strong foundation for larger, more comprehensive studies. The addition of cellular treatment with current in-utero repair procedures presents significant potential for transforming outcomes for babies yet to be born with myelomeningocele.

Written by

Michael Young

A tech journalist and software developer with over a decade of experience covering AI advancements and digital transformation.

TechSphere

Type to search articles.